June 2, 2020
Authored and Edited by Linda J. Thayer; Kara A. Specht; Elizabeth D. Ferrill
In McRO, Inc. dba Planet Blue v. Bandai Namco Games America Inc., et al., No. 2019-1577 (Fed. Cir. May 20, 2020), the Federal Circuit affirmed a district court’s decision of noninfringement but, for a second time, reversed the finding of invalidity, remanding to the Central District of California for reconsideration of enablement. Because Defendants offered to withdraw their invalidity counterclaims without prejudice, this long-running dispute has likely come to an end.
McRO asserted a patent related to a method of “automatically” generating 3-D animations depicting lip movements and facial expressions using morph weight sets, including a simple exemplary set of rules. In 2012, McRO sued over 20 video game developers, accusing software applications with “bones animation” to make video game images look three-dimensional. The CDCA found the claims invalid under Section 101. The Federal Circuit reversed finding that claims recited a technical means for accomplishing a particular objective do not present preemption concerns, so long as there exists the possibility of alternative technical means for accomplishing that same objective.
Once returned to the CDCA, the court returned a decision of noninfringement, finding the “bones animation” method used by Defendants did not practice the "morph weight set" limitation as narrowly understood based on the intrinsic evidence in the patent itself, not a broader interpretation that may exist in the field of art. In November 2018, the court granted defendants’ motion for summary judgment of invalidity, noting that defendants had identified two animation techniques—the accused “bones” animation and the prior art BALDI system—not enabled by the specification.
The Federal Circuit affirmed the finding of noninfringement. The Court, however, reversed the lower court’s finding of invalidity for failing to meet the enablement requirement because it failed to provide specific examples sufficient to support summary judgment. The Court summarized that Section 112 requires enablement of “only the claimed invention,” not matter outside the claims. Because both examples proffered by Defendants and considered by the lower court—“bones” animation and the BALDI system—were outside the scope of the claims, they could not support nonenablement. Judge Taranto wrote, "We do not go so far as to hold that there is a triable issue of fact on enablement—instead, we vacate the judgment and remand for the district court to consider how to proceed,” noting that Defendants had offered to drop their counterclaims of invalidity.
Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.